vs
iRhythm Holdings, Inc.（IRTC）与TANDEM DIABETES CARE INC（TNDM）财务数据对比。点击上方公司名可切换其他公司
TANDEM DIABETES CARE INC的季度营收约是iRhythm Holdings, Inc.的1.4倍（$290.4M vs $208.9M），iRhythm Holdings, Inc.净利率更高（2.7% vs -0.2%，领先2.9%），iRhythm Holdings, Inc.同比增速更快（27.1% vs 2.7%），iRhythm Holdings, Inc.自由现金流更多（$14.5M vs $3.1M），过去两年iRhythm Holdings, Inc.的营收复合增速更高（25.8% vs 23.1%）
iRhythm Holdings是一家专注于心脏护理领域的数字医疗企业，开发可穿戴动态心脏监测设备及配套AI分析工具，主要服务美国市场的医疗机构与患者，帮助检测房颤等心律异常病症，为临床诊断提供可靠的数据支持。
坦迪糖尿病护理公司是总部位于美国加利福尼亚州圣地亚哥的医疗器械制造商，专注于开发糖尿病治疗相关医疗技术，尤其深耕胰岛素输注治疗领域，为糖尿病患者提供对应的创新治疗解决方案。
IRTC vs TNDM — 直观对比
营收规模更大
TNDM
是对方的1.4倍
$208.9M
营收增速更快
IRTC
高出24.4%
2.7%
净利率更高
IRTC
高出2.9%
-0.2%
自由现金流更多
IRTC
多$11.4M
$3.1M
两年增速更快
IRTC
近两年复合增速
23.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $208.9M | $290.4M |
| 净利润 | $5.6M | $-589.0K |
| 毛利率 | 70.9% | 57.7% |
| 营业利润率 | 1.1% | 2.9% |
| 净利率 | 2.7% | -0.2% |
| 营收同比 | 27.1% | 2.7% |
| 净利润同比 | 518.5% | -178.0% |
| 每股收益（稀释后） | $0.18 | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRTCTNDM
| Q4 25 | $208.9M | $290.4M | ||
| Q3 25 | $192.9M | $249.3M | ||
| Q2 25 | $186.7M | $240.7M | ||
| Q1 25 | $158.7M | $234.4M | ||
| Q4 24 | $164.3M | $282.6M | ||
| Q3 24 | $147.5M | $244.0M | ||
| Q2 24 | $148.0M | $221.9M | ||
| Q1 24 | $131.9M | $191.7M |
净利润IRTCTNDM
| Q4 25 | $5.6M | $-589.0K | ||
| Q3 25 | $-5.2M | $-21.2M | ||
| Q2 25 | $-14.2M | $-52.4M | ||
| Q1 25 | $-30.7M | $-130.6M | ||
| Q4 24 | $-1.3M | $755.0K | ||
| Q3 24 | $-46.2M | $-23.3M | ||
| Q2 24 | $-20.1M | $-30.8M | ||
| Q1 24 | $-45.7M | $-42.7M |
毛利率IRTCTNDM
| Q4 25 | 70.9% | 57.7% | ||
| Q3 25 | 71.1% | 53.9% | ||
| Q2 25 | 71.2% | 52.3% | ||
| Q1 25 | 68.8% | 50.5% | ||
| Q4 24 | 70.0% | 55.7% | ||
| Q3 24 | 68.8% | 51.1% | ||
| Q2 24 | 69.9% | 50.8% | ||
| Q1 24 | 66.3% | 49.4% |
营业利润率IRTCTNDM
| Q4 25 | 1.1% | 2.9% | ||
| Q3 25 | -4.4% | -9.2% | ||
| Q2 25 | -10.0% | -21.5% | ||
| Q1 25 | -20.5% | -51.6% | ||
| Q4 24 | -2.5% | -0.2% | ||
| Q3 24 | -34.1% | -10.7% | ||
| Q2 24 | -15.5% | -13.9% | ||
| Q1 24 | -28.9% | -21.7% |
净利率IRTCTNDM
| Q4 25 | 2.7% | -0.2% | ||
| Q3 25 | -2.7% | -8.5% | ||
| Q2 25 | -7.6% | -21.8% | ||
| Q1 25 | -19.3% | -55.7% | ||
| Q4 24 | -0.8% | 0.3% | ||
| Q3 24 | -31.3% | -9.5% | ||
| Q2 24 | -13.6% | -13.9% | ||
| Q1 24 | -34.6% | -22.3% |
每股收益（稀释后）IRTCTNDM
| Q4 25 | $0.18 | $0.02 | ||
| Q3 25 | $-0.16 | $-0.31 | ||
| Q2 25 | $-0.44 | $-0.78 | ||
| Q1 25 | $-0.97 | $-1.97 | ||
| Q4 24 | $-0.03 | $0.00 | ||
| Q3 24 | $-1.48 | $-0.35 | ||
| Q2 24 | $-0.65 | $-0.47 | ||
| Q1 24 | $-1.47 | $-0.65 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $583.8M | $292.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $152.7M | $155.2M |
| 总资产 | $1.0B | $881.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IRTCTNDM
| Q4 25 | $583.8M | $292.7M | ||
| Q3 25 | $565.2M | $319.1M | ||
| Q2 25 | $545.5M | $315.4M | ||
| Q1 25 | $520.6M | $368.6M | ||
| Q4 24 | $535.6M | $438.3M | ||
| Q3 24 | $522.0M | $473.3M | ||
| Q2 24 | $561.5M | $452.4M | ||
| Q1 24 | $569.1M | $467.8M |
股东权益IRTCTNDM
| Q4 25 | $152.7M | $155.2M | ||
| Q3 25 | $121.9M | $133.0M | ||
| Q2 25 | $103.7M | $133.3M | ||
| Q1 25 | $86.7M | $155.3M | ||
| Q4 24 | $90.9M | $263.1M | ||
| Q3 24 | $71.8M | $237.7M | ||
| Q2 24 | $99.2M | $233.9M | ||
| Q1 24 | $90.3M | $243.1M |
总资产IRTCTNDM
| Q4 25 | $1.0B | $881.1M | ||
| Q3 25 | $995.2M | $874.7M | ||
| Q2 25 | $964.0M | $875.7M | ||
| Q1 25 | $926.1M | $922.1M | ||
| Q4 24 | $931.4M | $967.7M | ||
| Q3 24 | $909.7M | $957.7M | ||
| Q2 24 | $919.2M | $937.5M | ||
| Q1 24 | $909.8M | $941.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.2M | $9.8M |
| 自由现金流经营现金流 - 资本支出 | $14.5M | $3.1M |
| 自由现金流率自由现金流/营收 | 6.9% | 1.1% |
| 资本支出强度资本支出/营收 | 5.6% | 2.3% |
| 现金转化率经营现金流/净利润 | 4.70× | — |
| 过去12个月自由现金流最近4个季度 | $34.5M | $-29.7M |
8季度趋势，按日历期对齐
经营现金流IRTCTNDM
| Q4 25 | $26.2M | $9.8M | ||
| Q3 25 | $34.9M | $8.3M | ||
| Q2 25 | $27.7M | $-9.5M | ||
| Q1 25 | $-7.9M | $-18.3M | ||
| Q4 24 | $19.2M | $10.7M | ||
| Q3 24 | $24.3M | $26.8M | ||
| Q2 24 | $11.8M | $-5.3M | ||
| Q1 24 | $-52.0M | $-8.0M |
自由现金流IRTCTNDM
| Q4 25 | $14.5M | $3.1M | ||
| Q3 25 | $20.1M | $4.2M | ||
| Q2 25 | $17.3M | $-15.7M | ||
| Q1 25 | $-17.3M | $-21.2M | ||
| Q4 24 | $12.4M | $7.6M | ||
| Q3 24 | $15.5M | $21.5M | ||
| Q2 24 | $3.4M | $-11.7M | ||
| Q1 24 | $-61.8M | $-12.5M |
自由现金流率IRTCTNDM
| Q4 25 | 6.9% | 1.1% | ||
| Q3 25 | 10.4% | 1.7% | ||
| Q2 25 | 9.3% | -6.5% | ||
| Q1 25 | -10.9% | -9.1% | ||
| Q4 24 | 7.5% | 2.7% | ||
| Q3 24 | 10.5% | 8.8% | ||
| Q2 24 | 2.3% | -5.3% | ||
| Q1 24 | -46.8% | -6.5% |
资本支出强度IRTCTNDM
| Q4 25 | 5.6% | 2.3% | ||
| Q3 25 | 7.7% | 1.6% | ||
| Q2 25 | 5.6% | 2.6% | ||
| Q1 25 | 5.9% | 1.3% | ||
| Q4 24 | 4.2% | 1.1% | ||
| Q3 24 | 6.0% | 2.1% | ||
| Q2 24 | 5.7% | 2.9% | ||
| Q1 24 | 7.4% | 2.3% |
现金转化率IRTCTNDM
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 14.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
TNDM
| Supplies And Other | $150.3M | 52% |
| Pump | $140.1M | 48% |
